Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 448-454

  Maoret, Jean José ^a   Anini, Younes ^a   Rouyer Fessard, Christiane ^a   Gully, Danielle ^b   Laburthe, Marc ^a  

^a INSERM   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; NEUROTENSIN; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR ANTAGONIST; NEUROTENSIN[1-11]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

AGAR; ANIMALS; CELL DIVISION; COLONIC NEOPLASMS; CULTURE MEDIA; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEUROTENSIN; POLYMERASE CHAIN REACTION; PYRAZOLES; QUINOLINES; RECEPTORS, NEUROTENSIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032961942     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<448::AID-IJC19>3.0.CO;2-N     Document Type: Article

References (27)

1. AUGERON, C. and LABOISSE, C., Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res., 44, 3961-3969 (1984).
2. AUGERON, C., VOISIN, T., MAORET, J.J., BERTHON, B., LABURTHE, M. and LABOISSE, C.L., Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors. Amer. J. Physiol., 262, G470-G476 (1992).
3. BISHOP, D.T. and HALL, N.R., The genetics of colorectal cancer. Europ. J. Cancer, 30A, 1946-1956 (1994).
4. BOLAND, C.R., Malignant tumors of the colon. In: T. Yamada (ed.), Textbook of gastroenterology, pp. 1967-2026, Lippincott, Philadelphia (1995).
5. CARRAWAY, R.E. and LEEMAN, S.E., Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J. biol. Chem., 251, 7045-7052 (1976).
6. CHALON, P., VITA, N., KAGHAD, M., GUILLEMOT, M., BONNIN, J., DELPECH, B., LE FUR, G., FERRARA, P. and CAPUT, D., Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett., 386, 91-94 (1996).
7. CHUNG, D.H., EVERS, B.M., SHIMODA, I., TOWNSEND, C.M., RAJARAMAN, S. and THOMPSON, J.C., Effect of neurotensin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas. Gastroenterology, 103, 1254-1259 (1992).
8. EVERS, B.M., ISHIZUKA, J., CHUNG, D.H., TOWNSEND, C.M. and THOMPSON, J.C., Neurotensin expression and release in human colon cancers. Ann. Surg., 216, 423-431 (1992a).
9. EVERS, B.M., IZUKURA, M., CHUNG, D.H., PAREKH, D., YOSHINAGA, K., GREELEY, G.H., UCHIDA, T., TOWNSEND, C.M. and THOMPSON, J.C., Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology, 103, 86-91 (1992b).
10. FERRIS, C.F., Neurotensin. In: G.M. Makhlouf (ed.) Handbook of physiology. The gastrointestinal system. Neural and endocrine biology, sect. 6, vol. II, pp. 559-586, American Physiological Society, Bethesda, MD (1989).
11. GULLY, D. and 17 OTHERS, Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. nat. Acad. Sci. (Wash.), 90, 65-69 (1993).
12. IWASE, K., EVERS, B.M., HELLMICH, M.R., KIM, H.J., HIGASHIDE, S., GULLY, D., THOMPSON, J.C. and TOWNSEND, C.M., Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR 48692. Cancer. 79, 1787-1793 (1997).
13. IWASE, K., EVERS, B.M., HELLMICH, M.R., KIM, H.J., HIGASHIDE, S., GULLY, D. and TOWNSEND, C.M., Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. Surg. Oncol., 5, 245-251 (1996).
14. LABOISSE, C.L., MAORET, J.J., TRIADOU, N. and AUGERON, C., Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29. Cancer Res., 48, 2498-2504 (1988).
15. LABURTHE, M. and AMIRANOFF, B., Peptide receptors in intestinal epithelium. In: G.M. Makhlouf (ed.), Handbook of physiology. The gastrointestinal system. Neural and endocrine biology, sect. 6, vol. II, pp. 215-243. American Physiological Society, Bethesda, MD (1989).
16. LABURTHE, M., KITABGI, P., COUVINEAU, A. and AMIRANOFF, B., Peptide receptors and signal transduction in the digestive tract. Handbook exp. Phamacol., 106, 133-176 (1993).
17. LABURTHE, M., ROUSSET, M., BOISSARD, C., CHEVALIER, G., ZWEIBAUM, A. and ROSSELIN, G., Vasoactive intestinal peptide (VIP): a potent stimulator of adenosine 3′,5′:cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc. nat. Acad. Sci. (Wash.), 75, 2772-2775 (1978).
18. LABURTHE, M., ROUSSET, M., ROUYER-FESSARD, C., COUVINEAU, A., CHANTRET, I., CHEVALIER, G. and ZWEIBAUM, A., Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level. J. biol. Chem., 262, 10180-10184 (1987).
19. MAORET, J.J., POSPAI, D., ROUYER-FESSARD, C., COUVINEAU, A., LABOISSE, C., VOISIN, T. and LABURTHE, M., Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Biochem. biophys. Res. Comm., 203, 465-171 (1994).
20. POTTER, J.D., Hormones and colon cancer. J. nat. Cancer Inst., 87, 1039-1040 (1995).
21. POUYSSÉGUR, J. and SEUWEN, K., Transmembrane receptors and intracellular pathways that control cell proliferation. Ann. Rev. Physiol. 54, 195-210 (1992).
22. ROVÈRE, C., BARBERO, P., MAORET, J.J., LABURTHE, M. and KITABGI, P., Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines. Biochem. biophys. Res. Comm., 246, 155-159 (1998).
23. SEETHALAKSHMI, L., MITRA, S.P., DOBNER, P.R., MENON, M. and CARRAWAY, R.E., Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate, 31, 183-192 (1997).
24. SEGHAL, I., POWERS, S., HUNTLEY, B., POWIS, G., PITTLEKOW, M. and MAILHE, N.J., Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc. nat. Acad. Sci. (Wash.), 91, 4673-4677 (1994).
25. SINGH, P., TOWNSEND, C.M., THOMPSON, J.C., NARAYAN, S. and GUO, Y.S., Gut hormones in colon cancer: past and perspectives. Cancer J., 3, 28-33 (1990).
26. TANAKA, K., MASU, M. and NAKANISHI, S., Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 4, 847-854 (1990).
27. VITA, N., LAURENT, P., LEFORT, S., CHALON, P., DUMONT, X., KAGHAD, M., GULLY, D., LE FUR, G., FERRARA, P. and CAPUT, D., Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett., 317, 139-142 (1993).